Larotaxel

未知生产厂商

Larotaxel has been used in trials studying the treatment of Cancer, Metastases, Breast Cancer, Breast Neoplasms, and Pancreatic Neoplasms, among others.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Larotaxel has been used in trials studying the treatment of Cancer, Metastases, Breast Cancer, Breast Neoplasms, and Pancreatic Neoplasms, among others.

技术标识符

化学式: C₄₅H₅₃NO₁₄
CAS 编号: 156294-36-9
UNII ID: TWQ8K8A81Y

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PHARMACEUTICAL COMPOSITION CONTAINING TAXANE NANOAGGREGATES AND USE THEREOF
US 2024016754 A1申请人: FULGENT PHARMA LLC优先权: 2021
US
WO
4 件公开
Oral taxane compositions and methods
US 10835511 B2申请人: ATHENEX HK INNOVATIVE LTD优先权: 2016
US
2 件公开
DEUTERIUM-ENRICHED LAROTAXEL
US 2009076127 A1申请人: PROTIA LLC优先权: 2008
US
METHOD AND COMPOSITIONS FOR TREATMENT OF CANCER
US 2009246291 A1申请人: BURGER ANGELIKA优先权: 2009
US
Simple and efficient method for preparing paclitaxel analogue Larotaxel
CN 101863861 A申请人: SHANDONG TARGET DRUG RES CO LTD优先权: 2009
CN
Lipid microsphere injection of larotaxel phospholipid compound, and preparation method thereof
CN 102210652 A申请人: SHANDONG BADIAN PHARMACEUTICAL RES CO LTD优先权: 2010
CN
Simple and efficient method for preparing taxol analog Larotaxel
CN 102757410 A申请人: WUXI TARGET DRUG RES CO LTD优先权: 2011
CN
Taxane derivative purifying method
CN 104710389 A申请人: SUZHOU LEINA PHARMACEUTICAL RES DEV CO LTD优先权: 2013
CN
Micelle lyophilized preparation of nonlinear mannan-polylactic acid segmented copolymer supported taxane medicines, as well as preparation method and application thereof
CN 105982855 A申请人: SHANDONG HUBBLE KISEN BIOLOGICAL TECH CO LTD优先权: 2016
CN
Preparation method of larotaxel
CN 109206386 A申请人: JIANGSU HANBON SCI & TECH CO优先权: 2017
CN

药物